CME vs MSCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

CME

47.7
AI Score
VS
MSCI Wins

MSCI

55.0
AI Score

Investment Advisor Scores

CME

48score
Recommendation
HOLD

MSCI

55score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CME MSCI Winner
Forward P/E 21.9298 24.6914 CME
PEG Ratio 4.7092 1.866 MSCI
Revenue Growth 0.8% 12.2% MSCI
Earnings Growth 2.5% 19.6% MSCI
Tradestie Score 47.7/100 55.0/100 MSCI
Profit Margin 63.4% 40.7% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY MSCI

Relative Price Performance (Last 90 Days)

CME 1M: -5.3% · 3M: +12.1% MSCI 1M: -4.4% · 3M: -12.7%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.6 · Price: $263.14

MSCI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $535.95

Fundamentals Snapshot

Metric CME MSCI
Market Cap — —
Forward P/E 20.4 23.8
Trailing P/E 22.2 29.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.8%
Operating Margin 0.7% 0.6%
EPS 11.93 18.26
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, MSCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.